GL1X · GenesisL1 explorer

MolNFT v1 · #31176 · protein

Crystal structure of SARS_COV mpro in complex with an inhibitor N9

2AMD · 3C-like proteinase: “Crystal structure of SARS_COV mpro in complex with an inhibitor N9”. X-ray diffraction, 1 ligand (9IN), 5 pockets (best druggability 0.77). MolNFT v1 #31176 on GenesisL1: 3D structure, binding sites and pockets…

PDB
2AMD
Type
protein
Length
613 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.-
UniProt
P59641
Ligands
9IN
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.-)protein30925% helix, 28% strandP59641
B3C-like proteinase (EC 3.4.22.-)protein30426% helix, 29% strandP59641

Ligands and binding sites

  • 9IN · N-(3-furoyl)-D-valyl-L-valyl-N~1~-((1R,2Z)-4-ethoxy-4-oxo-1-{[(3S)-2-oxopyrrolidin-3-yl]methyl}but-2-enyl)-D-leucinamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18340.770.8065empty
25690.640.7588empty
32150.540.78349IN
42070.540.78289IN
51820.500.7730empty

Interfaces

1 interface between chains.

  • A–B · 1522 Ų buried · 32 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 2AMD · Crystal Structure Of SARS_CoV Mpro in Complex with an Inhibitor N9 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.